Second World Parkinson Congress

描述(由申请人提供)：第二届世界帕金森大会(WPC 2010)的目的是满足全球对话的需要，以解决帕金森病的多方面问题，并提出解决方案，包括为帕金森病患者提供新的研究方法和更好的治疗方案。2010年世界帕金森氏病大会将于2010年9月28日至10月1日在苏格兰格拉斯哥举行，这是帕金森氏病(PD)领域唯一一次国际会议，旨在回应将整个帕金森病社区聚集在一起举行高级别科学和非正式会议的需求。出席会议的代表将代表来自50多个国家的神经科学家、医生、帕金森病患者、护理人员、护士、相关卫生专业人员、政府代表和其他倡导社区成员。为期四天的计划强调了目前正在进行的工作，以促进帕金森病的科学研究，并改善对患有这种疾病的人的护理。让美国的研究人员接触到世界其他地区取得的科学进步，将有助于他们探索新想法，建立合作关系，否则他们可能不会建立合作关系。PD社区的广泛支持和参与将使WPC能够为社区的异花授粉创造一个场所，以建立卫生专业人员、研究人员和患者之间的合作和互动，否则他们可能不会见面。这些互动将刺激创新研究，确定未得到满足的需求的解决方案，并推进帕金森病患者的治疗。包括帕金森病患者在内的总共75名委员会成员中的38名设计了一项精心设计的计划，以提高科学家和临床医生对帕金森病独特方面的认识，以深化他们对帕金森病研究的承诺，并可能促进对帕金森病较少研究方面的研究。与此同时，预计该项目将使患者和护理人员接触到研究，并理想地提高参与临床试验的意愿和兴趣，这是当今研究人员面临的一大挑战。为最大限度地发挥学习潜力和进行对话，邀请了来自PD社区所有领域的发言者，包括最多1 000名代表的全会、200-550名代表的平行会议以及约100名代表的更亲密的研讨会。上午的全体会议围绕一个主题设计，作为所有与会者的会议场地，以一个主题开始每一天，为随后的会议奠定基础，并刺激当天晚些时候的进一步讨论。平行会议和研讨会将涵盖1)科学的新发展，2)临床护理的概念，3)与生活质量有关的问题；提供为期一天的讨论，以保持科学家、临床医生和患者的不同兴趣。大会的每一天都会有科学和帕金森生活的海报，这些海报都经过了项目委员会的审查和接受。这一范围广泛的海报会议旨在最大限度地促进研究人员、临床医生、患者和职业之间的互动。每天最杰出的三张海报将在每天开始的“热门话题”环节中公布。将举行海报巡回演出，密切关注实地最有希望的工作，并加强民主党派利益攸关方之间的对话与合作。 公共卫生相关性：第二届世界帕金森大会的目的是创建一个全球对话，讨论帕金森病的多方面问题，提出解决方案，包括新的研究方法，建立创新的合作，并为帕金森病患者创造更好的治疗选择。这是帕金森氏病(PD)领域唯一一次会议，满足了将整个PD社区聚集在一起举行高级别科学会议和讨论当前正在进行的工作的需要，这些工作旨在推进科学，改善对PD患者的护理，帮助研究人员敏感地了解PD患者的需求，反过来帮助患者了解研究人员和卫生专业人员在研究PD时面临的挑战。独特的是，出席会议的代表代表了神经学家、医生、帕金森病患者、护理人员、护士、相关卫生专业人员、政府代表和倡导社区的其他成员。

DESCRIPTION (provided by applicant): The purpose of the 2nd World Parkinson Congress (WPC 2010) is to address a need for worldwide dialogue to address the multifaceted problems of PD and propose solutions including new approaches to research and better treatment options for people with PD. The WPC 2010, to be held from September 28 - October 1, 2010 in Glasgow, Scotland is the only international meeting in the field of Parkinson's disease (PD) responding to a need to bring the whole PD community together for high-level scientific and lay sessions. Delegates at the meeting will represent neuroscientists, physicians, people with PD, caregivers, nurses, allied health professionals, government representatives, and other members of the advocacy community from more than 50 countries. The four-day program highlights current work being done to advance the science of PD and to improve care for people living with the disease. Exposing researchers from the US to the scientific advancements made in other parts of the world will help them explore new ideas and build collaborations they might otherwise not build. Broad support and involvement from the PD community will allow the WPC to create a venue for cross pollination of the community to build collaborations and interactions between health professionals, researchers, and patients who might not otherwise meet. These interactions will spur innovative research, identify solutions to unmet needs and advance therapies for people with PD. Thirty-eight, of a total of 75 committee members, including people living with PD, designed an elaborate program to raise awareness among scientists and clinicians about unique aspects of PD to deepen their commitment to PD research and possibly foster research on less studied aspects of PD. At the same time, the program is expected to expose patients and caregivers to research and ideally increase willingness and interest in participating in clinical trials, which is a major challenge for researchers today. Speakers are being invited from all areas of the PD community with sessions formatted in a variety of ways to maximize the learning potential and dialogue, including plenaries with up to 1,000 delegates, parallel sessions with 200 - 550 delegates and more intimate workshops, of around 100 delegates. The morning plenaries are designed around a theme and used as a meeting ground for all attendees to start each day with a topic that sets the stage for following sessions and stimulates further discussion later in the day. Parallel sessions and workshops will cover 1) new developments in science, 2) concepts on clinical care, and 3) issues related to quality of life; providing day-long discussions to hold the diverse interest of scientists, clinicians, and patients. There will be both Scientific and Living with Parkinson's posters each day of the Congress that were reviewed and accepted by the Program Committee. This broad range of posters sessions is designed to maximize interaction among researchers, clinicians, patients, and careers. The three most outstanding posters each day will be presented in a 'Hot Topics' session at the beginning of each day. Poster tours will be held paying keen attention to the most promising work in the field and to increase dialogue and collaboration between the stakeholders in the PD community. PUBLIC HEALTH RELEVANCE: The purpose of the 2nd World Parkinson Congress is to create a worldwide dialogue to discuss the multifaceted problems of PD, propose solutions including new approaches to research, build innovative collaborations, and create better treatment options for people with PD. It is the only meeting in the field of Parkinson's disease (PD) that addresses a need to bring the whole PD community together for high-level scientific sessions and discussions on current work being done to advance science, improve care for people with PD and help sensitize researchers to the needs of people with PD and conversely help patients understand the challenges researchers and health professionals face when studying PD. Uniquely, the delegates at the meeting represent neuroscientists, physicians, people with PD, caregivers, nurses, allied health professionals, government representatives, and other members of the advocacy community.